Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology

We investigated the challenges of conducting IMPACT2, an ongoing randomized study that evaluates molecular testing and targeted therapy (ClinicalTrials.gov: NCT02152254). Patients with metastatic cancer underwent tumor profiling and were randomized between the two arms when eligibility criteria were...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Henry Hiep, Fu, Siqing, Hong, David S., Karp, Daniel D., Piha-Paul, Sarina, Subbiah, Vivek, Janku, Filip, Naing, Aung, Yap, Timothy A., Rodon, Jordi, Ajani, Jaffer A., Cartwright, Carrie, Johnson, Amber, Song, I-Wen, Beck, Jennifer, Kahle, Michael, Nogueras-Gonzalez, Graciela M., Miller, Vincent, Chao, Calvin, Vining, David J., Berry, Donald A., Meric-Bernstam, Funda, Tsimberidou, Apostolia-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612600/
https://www.ncbi.nlm.nih.gov/pubmed/36302890
http://dx.doi.org/10.1038/s41698-022-00317-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612600/
https://www.ncbi.nlm.nih.gov/pubmed/36302890
http://dx.doi.org/10.1038/s41698-022-00317-0

Ejemplares similares